Financial Ratios | Aarti Drugs Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY11729.60  -159.80 (-1.34%)
SENSEX39922.46  -599.64 (-1.48%)
  • top gainers
  • top losers
  • top volume
  • top value
  • indian indices
  • global indices

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE642.10-33.7 (-4.99 %)
PREV CLOSE (Rs.) 675.80
OPEN PRICE (Rs.) 655.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 78729
TODAY'S LOW / HIGH (Rs.)642.05 676.90
52 WK LOW / HIGH (Rs.)105.56 1025
NSE643.35-33.85 (-5 %)
PREV CLOSE( Rs. ) 677.20
OPEN PRICE (Rs.) 656.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 643.35 (9752)
VOLUME 1903443
TODAY'S LOW / HIGH(Rs.) 643.35 677.00
52 WK LOW / HIGH (Rs.)105.25 1026.95

Financial Ratios

Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Operational & Financial Ratios
   Earnings Per Share (Rs)60.6938.0634.9034.2928.38
   CEPS(Rs)20.4014.0312.9712.6010.87
   DPS(Rs)2.001.001.001.006.75
   Book NAV/Share(Rs)280.04230.45193.12167.72147.58
   Tax Rate(%)23.6931.5033.8929.4927.87
Margin Ratios
   Core EBITDA Margin(%)14.7013.5115.9914.7914.58
   EBIT Margin(%)12.3311.1812.9012.1111.62
   Pre Tax Margin(%)10.268.399.869.017.73
   PAT Margin (%)7.835.756.526.355.57
   Cash Profit Margin (%)10.538.489.699.348.53
Performance Ratios
   ROA(%)9.336.316.387.136.53
   ROE(%)23.6517.9719.2421.6020.65
   ROCE(%)21.3917.0117.3118.5018.33
   Asset Turnover(x)1.191.100.981.121.17
   Sales/Fixed Asset(x)1.811.661.441.641.75
   Working Capital/Sales(x)6.478.0710.9616.7019.21
Efficiency Ratios
   Fixed Capital/Sales(x)0.550.600.700.610.57
   Receivable days95.7197.4597.1089.0595.59
   Inventory Days57.8061.3670.5254.9750.69
   Payable days64.6868.0873.8267.6665.68
Valuation Parameters
   PER(x)8.3316.8314.5216.7916.02
   PCE(x)6.2011.419.7611.4210.46
   Price/Book(x)1.812.782.623.433.08
   Yield(%)0.400.160.200.171.49
   EV/Net Sales(x)0.861.291.401.551.36
   EV/Core EBITDA(x)5.819.438.569.508.59
   EV/EBIT(x)6.9611.5310.6611.8510.79
   EV/CE(x)0.981.381.251.551.40
   M Cap / Sales0.650.970.961.150.97
Growth Ratio
   Net Sales Growth(%)15.7125.524.054.853.92
   Core EBITDA Growth(%)25.165.134.338.163.93
   EBIT Growth(%)27.617.174.388.890.91
   PAT Growth(%)57.549.050.6219.03-11.04
   EPS Growth(%)59.459.051.7920.82-11.04
Financial Stability Ratios
   Total Debt/Equity(x)0.580.931.201.201.26
   Current Ratio(x)1.451.331.191.161.13
   Quick Ratio(x)0.930.910.740.730.77
   Interest Cover(x)5.954.014.253.902.98
   Total Debt/Mcap(x)0.320.340.460.350.41